Malformations congénitales majeurs (MCM)

Dossier thématique sur les travaux d'EPI-PHARE sur la grossesse, les nouveaux-nés et les enfants
Articles publiés dans des revues à Comité de lecture
  • Duchemin, T., Marty, L., Drouin, J., Miranda, S., Botton, J., Olié, V., Weill, A., & Dray-Spira, R. (2026). Identification of major congenital malformations based on healthcare databases in France : A proof-of-concept study using the epi-meres nationwide mother–child register. British Journal of Clinical Pharmacology. [lien]
  • Shahriari, P., Drouin, J., Miranda, S., Bougas, N., Botton, J., & Dray-Spira, R. (2025). Trends in Prenatal Exposure to Antiseizure Medications Over the Past Decade. Neurology, 105(4), e213933. [lien]
  • Tran, A., Zureik, M., Sibiude, J., Miranda, S., Drouin, J., Marty, L., Weill, A., Dray-Spira, R., Duval, X., & Tubiana, S. (2025). First-trimester exposure to macrolides and risk of major congenital malformations compared with amoxicillin : A French nationwide cohort study. PLOS Medicine, 22(4), e1004576. [lien]
  • Bernard, C., Duchemin, T., Marty, L., Drouin, J., Miranda, S., Semenzato, L., Botton, J., Chouchana, L., Dray-Spira, R., Weill, A., & Zureik, M. (2025). First-Trimester mRNA COVID-19 Vaccination and Risk of Major Congenital Anomalies. JAMA Network Open, 8(10), e2538039. [lien]
  • Meyer, A., Marty, L., Drouin, J., Weill, A., Carbonnel, F., & Dray-Spira, R. (2025). Risks of 75 major congenital malformations after in utero exposure to thiopurines and anti-TNF for maternal inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 0(0). [lien]
  • Rios, P., Herlemont, P., Fauque, P., Lacour, B., Jouannet, P., Weill, A., Zureik, M., Clavel, J., & Dray-Spira, R. (2024). Medically Assisted Reproduction and Risk of Cancer Among Offspring. JAMA Network Open, 7(5), e249429. [lien]
  • Coste, J., Blotiere, P.-O., Miranda, S., Mikaeloff, Y., Peyre, H., Ramus, F., Zureik, M., Weill, A., & Dray-Spira, R. (2020). Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs : A nationwide cohort study in France. Scientific Reports, 10(1), Article 1. [lien]
  • Blotiere, P.-O., Raguideau, F., Weill, A., Elefant, E., Perthus, I., Goulet, V., Rouget, F., Zureik, M., Coste, J., & Dray-Spira, R. (2019). Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology, 93(2), e167‑e180. [lien]